FIELD: medicine; oncology.
SUBSTANCE: group of inventions discloses a method of treating glioma, including administering a pharmaceutically acceptable amount of a PDE1 inhibitor to a subject in need thereof, where the PDE1 inhibitor is selected from any of the following compounds in free form or in the form of a pharmaceutically acceptable salt. A method of inhibiting cytokine release syndrome is also disclosed.
EFFECT: technical result is the implementation of the purpose of the claimed methods.
6 cl, 5 tbl, 7 dwg, 3 ex
| Title |
Year |
Author |
Number |
| METHODS OF TREATMENT |
2020 |
|
RU2822394C1 |
| CANNABINOIDS IN COMBINATION WITH NON-CANNABINOID CHEMOTHERAPEUTIC AGENTS (FOR INSTANCE, SERMS OR ALKYLATING AGENTS) |
2009 |
- Velasko Dies Gil'Ermo
- Gusman Pastor Manuehl'
- Lorente Mar
- Torres Sofija
|
RU2543034C2 |
| QUINOLINE DERIVATIVES FOR USE IN TREATMENT OR PREVENTION OF CANCER |
2019 |
- Pouletty Philippe
- Ehrlich Hartmut
- Scherrer Didier
- Tazi Jamal
|
RU2811417C2 |
| ANTICANCER COMPOSITION CONTAINING A RECOMBINANT ADENOVIRUS EXPRESSING A DESTRUCTIVE FACTOR FOR AN EXTRACELLULAR MATRIX |
2017 |
|
RU2742726C2 |
| CANCER TREATMENT WITH TG02 |
2017 |
- Estok, Thomas M.
- Weber, Eckard
- Parrott, Tracy
|
RU2749025C2 |
| USE OF ALPHAVIRUS IN PREPARATION OF ANTITUMOR DRUGS |
2015 |
- Yan, Guangmei
- Xiao, Xiao
- Hu, Jun
- Li, Kai
- Liang, Jiankai
- Lin, Yuan
- Zhang, Haipeng
- Lin, Suizhen
|
RU2693938C2 |
| ANTI-CANCER THERAPY, DIRECTED AGAINST CANCER STEM CELLS AND FORMS OF CANCER, RESISTANT TO TREATMENT BY MEDICATIONS |
2010 |
|
RU2568834C2 |
| DEOXYDERIVATIVES OF CYTIDINE OR URIDINE FOR USE IN THE TREATMENT OF CANCER |
2020 |
- Robertson, Adam Brajan
- Prikrylova, Terezya
|
RU2797489C2 |
| MEANS AND METHODS FOR CANCER TREATMENT AND/OR PREVENTION DEPENDING ON NATURAL AHR LIGAND |
2012 |
- Platten Mikhael
- Opitts Kristian
- Vik Volfgang
- Littsenburger Ulrike
|
RU2640913C2 |
| METHOD OF TREATING CANCER USING A COMBINATION OF CHK1 AND ATR INHIBITORS |
2015 |
- Helleday, Thomas
- Sanjiv, Kumar
|
RU2736219C2 |
